183 related articles for article (PubMed ID: 38732133)
1. Anticancer Effects of Mitoquinone via Cell Cycle Arrest and Apoptosis in Canine Mammary Gland Tumor Cells.
Lee R; Lee WY; Park HJ
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732133
[TBL] [Abstract][Full Text] [Related]
2. Antitumor Effects of Esculetin, a Natural Coumarin Derivative, against Canine Mammary Gland Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis.
Choi J; Yoo MJ; Park SY; Seol JW
Vet Sci; 2023 Jan; 10(2):. PubMed ID: 36851388
[TBL] [Abstract][Full Text] [Related]
3. Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27.
Bakirel T; Alkan FÜ; Üstüner O; Çinar S; Yildirim F; Erten G; Bakirel U
J Vet Med Sci; 2016 May; 78(4):657-68. PubMed ID: 26822118
[TBL] [Abstract][Full Text] [Related]
4. Antitumor Activity of Rivoceranib Against Canine Mammary Gland Tumor Cell Lines.
Lee JH; Li Q; An JH; Chae HK; Choi JW; Kim BJ; Song WJ; Youn HY
Anticancer Res; 2019 Oct; 39(10):5483-5494. PubMed ID: 31570442
[TBL] [Abstract][Full Text] [Related]
5. The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone.
Rao VA; Klein SR; Bonar SJ; Zielonka J; Mizuno N; Dickey JS; Keller PW; Joseph J; Kalyanaraman B; Shacter E
J Biol Chem; 2010 Nov; 285(45):34447-59. PubMed ID: 20805228
[TBL] [Abstract][Full Text] [Related]
6. In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD-0332991) for treating canine mammary tumours.
Schoos A; Knab VM; Gabriel C; Tripolt S; Wagner DA; Bauder B; Url A; Fux DA
Vet Comp Oncol; 2019 Dec; 17(4):507-521. PubMed ID: 31207004
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel suppresses proliferation and induces apoptosis through regulation of ROS and the AKT/MAPK signaling pathway in canine mammary gland tumor cells.
Ren X; Zhao B; Chang H; Xiao M; Wu Y; Liu Y
Mol Med Rep; 2018 Jun; 17(6):8289-8299. PubMed ID: 29658576
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effects of rivoceranib against canine melanoma and mammary gland tumour in vitro and in vivo mouse xenograft models.
Li Q; Kim YS; An JH; Kwon JA; Han SH; Song WJ; Youn HY
BMC Vet Res; 2021 Oct; 17(1):338. PubMed ID: 34702279
[TBL] [Abstract][Full Text] [Related]
9. Anti-influenza neuraminidase inhibitor oseltamivir phosphate induces canine mammary cancer cell aggressiveness.
de Oliveira JT; Santos AL; Gomes C; Barros R; Ribeiro C; Mendes N; de Matos AJ; Vasconcelos MH; Oliveira MJ; Reis CA; Gärtner F
PLoS One; 2015; 10(4):e0121590. PubMed ID: 25850034
[TBL] [Abstract][Full Text] [Related]
10. Atg7- and Keap1-dependent autophagy protects breast cancer cell lines against mitoquinone-induced oxidative stress.
Gonzalez Y; Aryal B; Chehab L; Rao VA
Oncotarget; 2014 Mar; 5(6):1526-37. PubMed ID: 24681637
[TBL] [Abstract][Full Text] [Related]
11. Melatonin decreases in vitro viability and migration of spheres derived from CF41.Mg canine mammary carcinoma cells.
Serrano C; Guzmán S; Arias JI; Torres CG
BMC Vet Res; 2019 Nov; 15(1):390. PubMed ID: 31684950
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors.
Saito T; Tamura D; Asano R
Oncol Rep; 2014 Apr; 31(4):1637-44. PubMed ID: 24503782
[TBL] [Abstract][Full Text] [Related]
13. Mitoquinone alleviates vincristine-induced neuropathic pain through inhibiting oxidative stress and apoptosis via the improvement of mitochondrial dysfunction.
Chen XJ; Wang L; Song XY
Biomed Pharmacother; 2020 May; 125():110003. PubMed ID: 32187955
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of MitoQ on oxidative stress-mediated senescence of canine bone marrow mesenchymal stem cells via activation of the Nrf2/ARE pathway.
Zhong L; Deng J; Gu C; Shen L; Ren Z; Ma X; Yan Q; Deng J; Zuo Z; Wang Y; Cao S; Yu S
In Vitro Cell Dev Biol Anim; 2021 Aug; 57(7):685-694. PubMed ID: 34518994
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer effect of palmatine through inhibition of the PI3K/AKT pathway in canine mammary gland tumor CMT-U27 cells.
Yoo MJ; Choi J; Jang YJ; Park SY; Seol JW
BMC Vet Res; 2023 Oct; 19(1):223. PubMed ID: 37880653
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone receptor (GHR) RNAi decreases proliferation and enhances apoptosis in CMT-U27 canine mammary carcinoma cell line.
Pawłowski KM; Popielarz D; Szyszko K; Gajewska M; Motyl T; Król M
Vet Comp Oncol; 2012 Mar; 10(1):2-15. PubMed ID: 22235976
[TBL] [Abstract][Full Text] [Related]
17. Fucoxanthin Exerts Anti-Tumor Activity on Canine Mammary Tumor Cells via Tumor Cell Apoptosis Induction and Angiogenesis Inhibition.
Jang H; Choi J; Park JK; Won G; Seol JW
Animals (Basel); 2021 May; 11(6):. PubMed ID: 34071074
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of apoptotic markers in HEI-OC1 cells treated with gentamicin with and without the mitochondria-targeted antioxidant mitoquinone.
Jadidian A; Antonelli PJ; Ojano-Dirain CP
Otol Neurotol; 2015 Mar; 36(3):526-30. PubMed ID: 25076226
[TBL] [Abstract][Full Text] [Related]
19. Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling.
Diao H; Cheng N; Zhao Y; Xu H; Dong H; Thamm DH; Zhang D; Lin D
BMC Vet Res; 2019 Aug; 15(1):276. PubMed ID: 31375107
[TBL] [Abstract][Full Text] [Related]
20. Citrate and celecoxib induce apoptosis and decrease necrosis in synergistic manner in canine mammary tumor cells.
Vahidi R; Safi S; Farsinejad A; Panahi N
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):22-8. PubMed ID: 26475384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
